COVID-19 Preparedness Statement

The health of ISOQOL members and conference attendees is our top priority. ISOQOL is closely monitoring information and global reports related to the novel coronavirus disease (COVID-19). We are staying abreast of updates from health organizations responsible for tracking and responding to the virus, including the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).

During these uncertain times, healthcare related research and its impact on patients’ quality of life remains more important than ever. At this time the ISOQOL 27th Annual Conference is proceeding as planned in October 2020.

However, in response to the pandemic and its effects on our members, ISOQOL Leadership is making the following changes to conference related deadlines:

Should COVID-19 necessitate any additional changes to the conference, we will provide further updates via email and post to www.ISOQOL.org. Please direct any questions to info@isoqol.org.

Deadline Extended Through 1 May

For Oral, Oral Brief, and Poster Abstracts

Submissions will remain open for 2020 Annual Conference oral, oral brief, and poster presentation abstracts through 1 May at 11:59 pm CDT.

Submissions related to the theory, methods, and application of health related quality of life research are welcome. Researchers, students, clinicians, regulatory agency professionals, industry representatives and patient research partners are all encouraged to submit abstracts for consideration.

Oral, oral brief, and poster abstract submissions are now due 1 May 2020.

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).

Together, we are creating a future in which patient perspective is integral to health research, care and policy.